BR9712587A - cido nucléico, molécula de ácido nucléico, sonda, vetor de expressão recombinante, célula, processos para produzir um polipeptìdeo de h. pylori e para detectar a presença de um ácido nucléico de helicobacter pylori em uma amostra, polipeptìdeo de h. pylori isolado, polipeptìdeos de envelope de célula, celular e secretado de h. pylori ou seus fragmentos, proteìna de fusão, formulação de vacina para a profilaxia ou tratamento de uma infecção por h. pylori, e, processos para tratar ou reduzir um risco de infecção por h. pylori em um sujeito e para produzir uma formulação de vacina. - Google Patents
cido nucléico, molécula de ácido nucléico, sonda, vetor de expressão recombinante, célula, processos para produzir um polipeptìdeo de h. pylori e para detectar a presença de um ácido nucléico de helicobacter pylori em uma amostra, polipeptìdeo de h. pylori isolado, polipeptìdeos de envelope de célula, celular e secretado de h. pylori ou seus fragmentos, proteìna de fusão, formulação de vacina para a profilaxia ou tratamento de uma infecção por h. pylori, e, processos para tratar ou reduzir um risco de infecção por h. pylori em um sujeito e para produzir uma formulação de vacina.Info
- Publication number
- BR9712587A BR9712587A BR9712587-3A BR9712587A BR9712587A BR 9712587 A BR9712587 A BR 9712587A BR 9712587 A BR9712587 A BR 9712587A BR 9712587 A BR9712587 A BR 9712587A
- Authority
- BR
- Brazil
- Prior art keywords
- pylori
- nucleic acid
- processes
- cell
- vaccine formulation
- Prior art date
Links
- 102000039446 nucleic acids Human genes 0.000 title abstract 6
- 108020004707 nucleic acids Proteins 0.000 title abstract 6
- 150000007523 nucleic acids Chemical class 0.000 title abstract 6
- 239000000203 mixture Substances 0.000 title abstract 5
- 229920001184 polypeptide Polymers 0.000 title abstract 5
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 5
- 229960005486 vaccine Drugs 0.000 title abstract 5
- 238000009472 formulation Methods 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 4
- 239000000523 sample Substances 0.000 title abstract 3
- 230000001413 cellular effect Effects 0.000 title abstract 2
- 239000013604 expression vector Substances 0.000 title abstract 2
- 239000012634 fragment Substances 0.000 title abstract 2
- 108020001507 fusion proteins Proteins 0.000 title abstract 2
- 238000011321 prophylaxis Methods 0.000 title abstract 2
- 238000003259 recombinant expression Methods 0.000 title abstract 2
- 238000011282 treatment Methods 0.000 title abstract 2
- 241000590002 Helicobacter pylori Species 0.000 title 1
- 102000037865 fusion proteins Human genes 0.000 title 1
- 229940037467 helicobacter pylori Drugs 0.000 title 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73915096A | 1996-10-28 | 1996-10-28 | |
| US75973996A | 1996-12-06 | 1996-12-06 | |
| US89192897A | 1997-07-14 | 1997-07-14 | |
| PCT/US1997/019575 WO1998018323A1 (en) | 1996-10-28 | 1997-10-28 | Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9712587A true BR9712587A (pt) | 1999-10-26 |
Family
ID=27419246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9712587-3A BR9712587A (pt) | 1996-10-28 | 1997-10-28 | cido nucléico, molécula de ácido nucléico, sonda, vetor de expressão recombinante, célula, processos para produzir um polipeptìdeo de h. pylori e para detectar a presença de um ácido nucléico de helicobacter pylori em uma amostra, polipeptìdeo de h. pylori isolado, polipeptìdeos de envelope de célula, celular e secretado de h. pylori ou seus fragmentos, proteìna de fusão, formulação de vacina para a profilaxia ou tratamento de uma infecção por h. pylori, e, processos para tratar ou reduzir um risco de infecção por h. pylori em um sujeito e para produzir uma formulação de vacina. |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0973394A4 (id) |
| JP (1) | JP2001504329A (id) |
| KR (1) | KR20000052831A (id) |
| CN (1) | CN1235513A (id) |
| AR (1) | AR009600A1 (id) |
| AU (1) | AU734052B2 (id) |
| BR (1) | BR9712587A (id) |
| CA (1) | CA2265523A1 (id) |
| EE (1) | EE9900176A (id) |
| ID (1) | ID22065A (id) |
| IL (1) | IL129397A0 (id) |
| IS (1) | IS5005A (id) |
| NO (1) | NO991995L (id) |
| NZ (1) | NZ334568A (id) |
| PL (1) | PL333169A1 (id) |
| SA (1) | SA98180918A (id) |
| SK (1) | SK34699A3 (id) |
| TR (1) | TR199900940T2 (id) |
| WO (1) | WO1998018323A1 (id) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE244578T1 (de) * | 1993-07-27 | 2003-07-15 | Csl Ltd | Behandlung eines durch helicobakter verursachten gastroduodenalen krankheit |
| US6406703B1 (en) | 1993-07-27 | 2002-06-18 | Csl Limited | Treatment of H. pylori associated gastroduodenal disease |
| DE19730425A1 (de) | 1997-07-16 | 1999-01-21 | Henkel Teroson Gmbh | Heißhärtende wäschefeste Rohbau-Versiegelung |
| EP1108033A2 (en) * | 1998-07-27 | 2001-06-20 | Aventis Pasteur Limited | $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| SE9901548D0 (sv) * | 1999-04-29 | 1999-04-29 | Astra Ab | Helicobacter pylori antigens |
| GB9914945D0 (en) * | 1999-06-25 | 1999-08-25 | Smithkline Beecham Biolog | Novel compounds |
| AUPQ347199A0 (en) * | 1999-10-15 | 1999-11-11 | Csl Limited | Novel polypeptide fragments |
| CN101532001A (zh) | 2000-03-08 | 2009-09-16 | 诺维信公司 | 具有改变的特性的变体 |
| GB0010370D0 (en) * | 2000-04-29 | 2000-06-14 | Astrazeneca Ab | Helicobacter pylori antigens |
| GB0010371D0 (en) * | 2000-04-29 | 2000-06-14 | Astrazeneca Ab | Helicobacter pylori antigens |
| WO2012124764A1 (ja) * | 2011-03-17 | 2012-09-20 | 国立大学法人三重大学 | 抗体の製造方法 |
| BR112018012033A2 (pt) * | 2015-12-14 | 2018-12-04 | Max Planck Gesellschaft | composição imunogênica e método para detectar infecção por h. pylori em um sujeito |
| CN115724922B (zh) * | 2022-07-19 | 2023-08-22 | 四川大学华西医院 | 一种幽门螺杆菌疫苗重组蛋白抗原TonB及其制备方法与应用 |
| CN115581201A (zh) * | 2022-08-26 | 2023-01-10 | 云南省农业科学院花卉研究所 | 以茎段为外植体诱导的二倍体月季f1-61的植株再生方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9300139L (sv) * | 1993-01-19 | 1994-07-20 | Medicarb Ab | Framställning av ett nytt läkemedel |
-
1997
- 1997-10-28 TR TR1999/00940T patent/TR199900940T2/xx unknown
- 1997-10-28 EP EP97913847A patent/EP0973394A4/en not_active Withdrawn
- 1997-10-28 PL PL97333169A patent/PL333169A1/xx unknown
- 1997-10-28 KR KR1019990703660A patent/KR20000052831A/ko not_active Application Discontinuation
- 1997-10-28 JP JP52071098A patent/JP2001504329A/ja active Pending
- 1997-10-28 AU AU50933/98A patent/AU734052B2/en not_active Ceased
- 1997-10-28 NZ NZ334568A patent/NZ334568A/xx unknown
- 1997-10-28 ID IDW990160A patent/ID22065A/id unknown
- 1997-10-28 SK SK346-99A patent/SK34699A3/sk unknown
- 1997-10-28 EE EEP199900176A patent/EE9900176A/xx unknown
- 1997-10-28 WO PCT/US1997/019575 patent/WO1998018323A1/en not_active Application Discontinuation
- 1997-10-28 CN CN97199233A patent/CN1235513A/zh active Pending
- 1997-10-28 CA CA002265523A patent/CA2265523A1/en not_active Abandoned
- 1997-10-28 AR ARP970105002A patent/AR009600A1/es not_active Application Discontinuation
- 1997-10-28 BR BR9712587-3A patent/BR9712587A/pt not_active IP Right Cessation
- 1997-10-28 IL IL12939797A patent/IL129397A0/xx unknown
-
1998
- 1998-02-28 SA SA98180918A patent/SA98180918A/ar unknown
-
1999
- 1999-03-18 IS IS5005A patent/IS5005A/is unknown
- 1999-04-27 NO NO991995A patent/NO991995L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20000052831A (ko) | 2000-08-25 |
| SK34699A3 (en) | 2000-04-10 |
| SA98180918A (ar) | 2005-12-03 |
| JP2001504329A (ja) | 2001-04-03 |
| PL333169A1 (en) | 1999-11-22 |
| NO991995D0 (no) | 1999-04-27 |
| WO1998018323A1 (en) | 1998-05-07 |
| AU734052B2 (en) | 2001-05-31 |
| EP0973394A4 (en) | 2005-03-30 |
| AU5093398A (en) | 1998-05-22 |
| AR009600A1 (es) | 2000-04-26 |
| NZ334568A (en) | 2000-04-28 |
| CA2265523A1 (en) | 1998-05-07 |
| NO991995L (no) | 1999-06-28 |
| IL129397A0 (en) | 2000-02-17 |
| EP0973394A1 (en) | 2000-01-26 |
| ID22065A (id) | 1999-08-26 |
| IS5005A (is) | 1999-03-18 |
| EE9900176A (et) | 1999-12-15 |
| TR199900940T2 (xx) | 1999-09-21 |
| CN1235513A (zh) | 1999-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9712587A (pt) | cido nucléico, molécula de ácido nucléico, sonda, vetor de expressão recombinante, célula, processos para produzir um polipeptìdeo de h. pylori e para detectar a presença de um ácido nucléico de helicobacter pylori em uma amostra, polipeptìdeo de h. pylori isolado, polipeptìdeos de envelope de célula, celular e secretado de h. pylori ou seus fragmentos, proteìna de fusão, formulação de vacina para a profilaxia ou tratamento de uma infecção por h. pylori, e, processos para tratar ou reduzir um risco de infecção por h. pylori em um sujeito e para produzir uma formulação de vacina. | |
| BR9809445A (pt) | Polipeptìdeo compreendendo uma porção imunogênica de um antìgeno de m. tubercolosis, molécula de dna, vetor de expressão, célula hospedeira, composição farmacêutica, vacina, proteìna de fusão, processos para indução de imunidade protetora em um paciente, processo de detecção de tuberculose em um paciente,e , kit de diagnóstico. | |
| MY120693A (en) | Human bikunin | |
| AU7201287A (en) | Recombinant human endothelial cell growth factor | |
| BR9307510A (pt) | Molécula de ácido nucleico purificada e isolada plasmídeo recombinante adaptado para transformação de hospedeiro vector recombinante adaptado para transformação de célula hospedeira proteína purificada e isolada proteína de membrana externa d15 peptídio sintético molécula quimérica composição imunogênica e anti-soro ou anticorpo | |
| BR0015137A (pt) | Peptìdeos antigênicos de neisseria | |
| Park et al. | Different forms of adrenal phenylethanolamine N‐methyltransferase: Species‐specific posttranslational modification | |
| NZ536232A (en) | Chimeric camp factors for vaccination against streptococcus infection | |
| Valentini et al. | Mammalian single-stranded DNA binding proteins and heterogeneous nuclear RNA proteins have common antigenic determinants | |
| Duguid et al. | The protein components of the gap junction | |
| Graf et al. | Cathepsin D generates γ-endorphin from β-endorphin | |
| BR9714133A (pt) | ácido nucleico isolado, molécula do mesmo, sonda, vetor de expressão recombinante, célula, polipeptìdeo, proteìna de fusão formulação de vacina e processos para produzir um polipeptìdeo de h. pylori, para detctar a presença de um ácido nucleico de helicobacter em uma amostra, para tratar ou reduzir um risco de infecção por h. pylori em um indivìduo e para produzir uma formulação de vacina | |
| IL84700A (en) | Hybrid proteins,dnas coding therefor,hybrid vectors containing such dnas and hosts transformed therewith,the preparation of such hybrid proteins and pharmaceutical compositions containing them | |
| Boime et al. | The synthesis of human placental lactogen by ribosomes derived from human placenta | |
| ES8704735A1 (es) | Un procedimiento para la obtencion de un anticuerpo monoclo-nal | |
| NO984491L (no) | SCF-analogpreparater og fremgangsmÕte for fremstilling av disse | |
| Senior et al. | Comparison of the elastolytic effects of human leukocyte elastase and porcine pancreatic elastase | |
| Isobe et al. | Isolation and characterization of des (Ala-Lys) calmodulin in porcine brain | |
| AU5776799A (en) | Modified hcv peptide vaccines | |
| Boulton et al. | Abnormal human myoglobin: 53 (D4) glutamic acid→ lysine | |
| Desai et al. | Carboxyl-terminal sequence of the glycine-arginine-rich histone from bovine lymphosarcoma, Novikoff hepatoma and fetal calf thymus | |
| Tan | Isolation and characterization of two toxins from the venom of the Malayan cobra (Naja naja sputatrix) | |
| Campbell et al. | Erythropoietin: III. Chemical charactirization of highly purified fractions from sheep erythropoietin concentrates | |
| Kubo | Variability in heat-induced fragmentation of a protein in the presence of dodecyl sulfate: the role of an intramolecular sulfhydryl/disulfide exchange | |
| Gimenez et al. | Pepsin fragmentation of botulinum type E neurotoxin: Isolation and characterization of 112, 48, 46, and 16 kD fragments |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 6A,7A,8A, 9A E 10A ANUIDADES |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1908 DE 31/07/2007. |